![Simon Pedder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Pedder
Directeur Général chez
Nirogy Therapeutics, Inc.
Profil
Simon C.
Pedder was the founder of Chelsea Therapeutics International Ltd., founded in 2005, where the titles held included President, Chief Executive Officer & Director from 2005 to 2012.
Current jobs include Chief Executive Officer at Nirogy Therapeutics, Inc. since 2022; Executive Chairman at Adaptin Bio, Inc. starting in 2025; and Director roles at Eboo Pharmaceuticals, Inc., Ballantyne Therapeutics, Inc., and Atlantic Research Group, Inc. Former jobs include President & Chief Executive Officer at Ivory Capital Corp.
from 2004 to 2005; President & Chief Executive Officer at Chelsea Therapeutics, Inc. from 2004 to 2012; Chief Executive Officer & Director at Novelos Therapeutics, Inc. from 2013 to 2014; President, Chief Executive Officer & Director at Cellectar Biosciences, Inc. from 2014 to 2015; Independent Director at Oncotelic Therapeutics, Inc. from 2016 to 2019; Independent Director at Delcath Systems, Inc. from 2017 to 2019; President & Director at Avalo Therapeutics, Inc. in 2020; Vice President at Oncology Pharma, Inc.; Chief Business & Strategy Officer-Proprietary at Athenex, Inc. from 2016 to 2021; Vice President-Pharmaceutical Business & Oncology at Hoffmann-La Roche, Inc.; Vice President-Drug Development at Shearwater Corp.
from 2001 to 2002; and Member at the University of Saskatchewan College of Medicine.
Education includes graduate degree from Concordia University, undergraduate degree from The University of Waterloo, and doctorate from the University of Saskatchewan College of Medicine.
Postes actifs de Simon Pedder
| Sociétés | Poste | Début |
|---|---|---|
Eboo Pharmaceuticals, Inc. | Directeur/Membre du Conseil | - |
Ballantyne Therapeutics, Inc.
 Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur/Membre du Conseil | - |
Atlantic Research Group, Inc.
 Atlantic Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical program development services | Directeur/Membre du Conseil | - |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | 12/01/2022 |
Anciens postes connus de Simon Pedder
| Sociétés | Poste | Fin |
|---|---|---|
| ATHENEXPAR | Corporate Officer/Principal | 31/12/2021 |
| AVALO THERAPEUTICS, INC. | Président | 24/04/2020 |
| ONCOTELIC THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/04/2019 |
| DELCATH SYSTEMS, INC. | Directeur/Membre du Conseil | 10/04/2019 |
| CELLECTAR BIOSCIENCES, INC. | Directeur Général | 15/06/2015 |
Formation de Simon Pedder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Oncology Pharma, Inc.
 Oncology Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Ivory Capital Corp.
 Ivory Capital Corp. Financial ConglomeratesFinance Development stage company | Finance |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Provides research services focused on health care applications of advanced PEGylation | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chelsea Therapeutics, Inc.
 Chelsea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of a variety of human diseases | Health Technology |
Novelos Therapeutics, Inc.
 Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Health Technology |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Eboo Pharmaceuticals, Inc. | |
University of Saskatchewan College of Medicine
 University of Saskatchewan College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ballantyne Therapeutics, Inc.
Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Atlantic Research Group, Inc.
Atlantic Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical program development services | Commercial Services |
Nirogy Therapeutics, Inc.
Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
